Lee F Allen Selected Research

avatrombopag

1/2020	Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies.
11/2018	Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies.
11/2018	Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia.
1/2018	Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lee F Allen Research Topics

Disease

5	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 02/2016 - 01/2014
4	Neoplasms (Cancer) 04/2016 - 06/2002
3	Hemorrhage 01/2020 - 01/2018
3	Liver Diseases (Liver Disease) 01/2020 - 01/2018
3	Thrombocytopenia (Thrombopenia) 01/2020 - 01/2018
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2016 - 03/2015
3	Fatigue 01/2016 - 01/2014
3	Chronic Disease (Chronic Diseases) 01/2016 - 01/2014
2	Chronic Renal Insufficiency 01/2016 - 01/2016
2	Breast Neoplasms (Breast Cancer) 10/2003 - 06/2002
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2018
1	Contusions 11/2018
1	Headache (Headaches) 11/2018
1	Hypotension (Low Blood Pressure) 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Hypersensitivity (Allergy) 01/2016
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2016
1	Multiple Myeloma 12/2015
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2003

Drug/Important Bio-Agent (IBA)

6	Ferrosoferric Oxide (Magnetite)FDA Link 02/2016 - 01/2014
5	IronIBA 02/2016 - 01/2014
4	avatrombopagIBA 01/2020 - 01/2018
3	belinostatIBA 04/2016 - 03/2015
2	Thrombopoietin ReceptorsIBA 11/2018 - 11/2018
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 01/2014
2	Saccharated Ferric Oxide (Venofer)FDA Link 01/2016 - 06/2014
2	Canertinib (CI 1033)IBA 10/2003 - 06/2002
2	ErbB-2 ReceptorIBA 10/2003 - 06/2002
2	ErbB Receptors (EGF Receptor)IBA 10/2003 - 06/2002
1	Inosine Triphosphate (ITP)IBA 11/2018
1	EnzymesIBA 04/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2016
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 12/2015
1	Melphalan (Alkeran)FDA LinkGeneric 12/2015
1	Biomarkers (Surrogate Marker)IBA 10/2003
1	Mitogen-Activated Protein KinasesIBA 10/2003
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2003
1	Indicators and Reagents (Reagents)IBA 06/2002

Therapy/Procedure

7	Therapeutics 11/2018 - 01/2014
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 10/2003 - 06/2002
1	Autologous Transplantation 12/2015
1	Stem Cell Transplantation 12/2015